Literature DB >> 20683670

Detection of hepatic metastases using dual-time-point FDG PET/CT scans in patients with colorectal cancer.

Jeong Won Lee1, Seok-Ki Kim2, Sang Mi Lee3, Seung Hwan Moon3, Tae-Sung Kim3.   

Abstract

PURPOSE: The purpose of this study was to determine the most useful parameter of dual-time-point 2-deoxy-2-[¹⁸F]fluoro-D: -glucose positron emission tomography/computed tomography (PET/CT) for detection of hepatic metastases in patients with colorectal cancer. PROCEDURES: Thirty-nine patients had undergone a dual-time-point PET/CT scan and a subsequent histopathological confirmation for a workup of hepatic metastases. Detection rates were compared for visual analysis score, standardized uptake value (SUV), tumor-to-liver uptake ratio (TLR), and percent changes of the SUV and TLR.
RESULTS: Of 91 liver lesions, 86 lesions were confirmed as metastases. The SUV and TLR of metastatic lesions on the delayed images were higher than those on the first scan (p < 0.001). The signal-to-noise ratio of the delayed PET scan was higher than that of the first scan (p < 0.0001). The TLR and SUV of the delayed scan showed the highest detection rates of 92% and 88%, whereas percent changes of SUV and TLR showed the lowest detection rates (51%, 67%). Visual analysis detected 87% on the delayed scan and 77% on the first scan.
CONCLUSIONS: A delayed scan is more favorable for the detection of hepatic metastases of colorectal cancer, and the TLR on the delayed scan was the most useful parameter.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 20683670     DOI: 10.1007/s11307-010-0394-x

Source DB:  PubMed          Journal:  Mol Imaging Biol        ISSN: 1536-1632            Impact factor:   3.488


  32 in total

1.  Quantification of [(18)F]FDG uptake in the normal liver using dynamic PET: impact and modeling of the dual hepatic blood supply.

Authors:  G Brix; S I Ziegler; M E Bellemann; J Doll; R Schosser; R Lucht; H Krieter; D Nosske; U Haberkorn
Journal:  J Nucl Med       Date:  2001-08       Impact factor: 10.057

2.  Dual-phase FDG-PET: delayed acquisition improves hepatic detectability of pathological uptake.

Authors:  V Arena; A Skanjeti; R Casoni; A Douroukas; E Pelosi
Journal:  Radiol Med       Date:  2008-07-10       Impact factor: 3.469

3.  Optimizing delayed scan time for FDG PET: comparison of the early and late delayed scan.

Authors:  Yu Mei Chen; Gang Huang; Xiao Guang Sun; Jian Jun Liu; Tao Chen; Yi Ping Shi; Liang Rong Wan
Journal:  Nucl Med Commun       Date:  2008-05       Impact factor: 1.690

4.  Optimizing imaging protocols for overweight and obese patients: a lutetium orthosilicate PET/CT study.

Authors:  Benjamin S Halpern; Magnus Dahlbom; Martin A Auerbach; Christiaan Schiepers; Barbara J Fueger; Wolfgang A Weber; Daniel H S Silverman; Osman Ratib; Johannes Czernin
Journal:  J Nucl Med       Date:  2005-04       Impact factor: 10.057

5.  The role of positron emission tomography with fluorine-18-deoxyglucose in identifying colorectal cancer metastases to liver.

Authors:  H Zhuang; P Sinha; M Pourdehnad; P S Duarte; A J Yamamoto; A Alavi
Journal:  Nucl Med Commun       Date:  2000-09       Impact factor: 1.690

6.  Comparison of imaging protocols for 18F-FDG PET/CT in overweight patients: optimizing scan duration versus administered dose.

Authors:  Yoko Masuda; Chisato Kondo; Yuka Matsuo; Masataka Uetani; Kiyoko Kusakabe
Journal:  J Nucl Med       Date:  2009-05-14       Impact factor: 10.057

7.  Hepatic resection for metastases from colorectal carcinoma--a survival analysis.

Authors:  G R Jatzko; P H Lisborg; H M Stettner; M H Klimpfinger
Journal:  Eur J Cancer       Date:  1995       Impact factor: 9.162

8.  Dual-time-point FDG-PET/CT for the detection of hepatic metastases.

Authors:  Albert Dirisamer; Benjamin S Halpern; Wolfgang Schima; Martin Heinisch; Florian Wolf; Mohsen Beheshti; Franz Dirisamer; Michael Weber; Werner Langsteger
Journal:  Mol Imaging Biol       Date:  2008-08-16       Impact factor: 3.488

9.  Increasing uptake time in FDG-PET: standardized uptake values in normal tissues at 1 versus 3 h.

Authors:  Bennett B Chin; Edward D Green; Timothy G Turkington; Thomas C Hawk; R Edward Coleman
Journal:  Mol Imaging Biol       Date:  2008-11-27       Impact factor: 3.488

10.  FDG-PET for evaluation of recurrent lymph node metastases in patients with surgically resected breast cancer: adding spot images to whole body images.

Authors:  Tsuneo Tamaki; Akihiro Naito; Masami Nishio; Katsuhiko Kawahara
Journal:  Breast Cancer       Date:  2004       Impact factor: 4.239

View more
  18 in total

1.  Comparison of lesion detection and quantitation of tracer uptake between PET from a simultaneously acquiring whole-body PET/MR hybrid scanner and PET from PET/CT.

Authors:  Marco Wiesmüller; Harald H Quick; Bharath Navalpakkam; Michael M Lell; Michael Uder; Philipp Ritt; Daniela Schmidt; Michael Beck; Torsten Kuwert; Carl C von Gall
Journal:  Eur J Nucl Med Mol Imaging       Date:  2012-10-06       Impact factor: 9.236

2.  The Clinical Role of Dual-Time-Point (18)F-FDG PET/CT in Differential Diagnosis of the Thyroid Incidentaloma.

Authors:  Sinae Lee; Taegyu Park; Soyeon Park; Kisoo Pahk; Seunghong Rhee; Jaehyuk Cho; Eugene Jeong; Sungeun Kim; Jae Gol Choe
Journal:  Nucl Med Mol Imaging       Date:  2013-12-06

3.  Total Body PET: Why, How, What for?

Authors:  Suleman Surti; Austin R Pantel; Joel S Karp
Journal:  IEEE Trans Radiat Plasma Med Sci       Date:  2020-04-03

Review 4.  KSNM60 in Clinical Nuclear Oncology.

Authors:  Seung Hwan Moon; Young Seok Cho; Joon Young Choi
Journal:  Nucl Med Mol Imaging       Date:  2021-08-31

5.  Dynamic changes of FDG uptake and clearance in normal tissues.

Authors:  Gang Cheng; Abass Alavi; Esther Lim; Thomas J Werner; Catherine V Del Bello; Scott R Akers
Journal:  Mol Imaging Biol       Date:  2013-06       Impact factor: 3.488

Review 6.  When should we recommend use of dual time-point and delayed time-point imaging techniques in FDG PET?

Authors:  Gang Cheng; Drew A Torigian; Hongming Zhuang; Abass Alavi
Journal:  Eur J Nucl Med Mol Imaging       Date:  2013-01-30       Impact factor: 9.236

7.  Standardized Uptake Values from PET/MRI in Metastatic Breast Cancer: An Organ-based Comparison With PET/CT.

Authors:  Akshat C Pujara; Roy A Raad; Fabio Ponzo; Carolyn Wassong; James S Babb; Linda Moy; Amy N Melsaether
Journal:  Breast J       Date:  2016-02-04       Impact factor: 2.431

8.  Usefulness of respiratory-gated PET acquisition during delayed 18F-FDG PET/CT scanning for patients with liver metastases.

Authors:  Shota Watanabe; Kohei Hanaoka; Hayato Kaida; Tomoko Hyodo; Minoru Yamada; Masakatsu Tsurusaki; Kazunari Ishii
Journal:  Asia Ocean J Nucl Med Biol       Date:  2021

9.  Current state of oncologic 18F-FDG PET/CT in Japan: A nationwide survey.

Authors:  Hajime Ichikawa; Toyohiro Kato; Kenta Miwa; Takayuki Shibutani; Koichi Okuda; Akio Nagaki; Hiroyuki Tsushima; Masahisa Onoguchi
Journal:  Asia Ocean J Nucl Med Biol       Date:  2021

10.  Accuracy of [18F]FDG PET/MRI for the Detection of Liver Metastases.

Authors:  Karsten Beiderwellen; Llanos Geraldo; Verena Ruhlmann; Philipp Heusch; Benedikt Gomez; Felix Nensa; Lale Umutlu; Thomas C Lauenstein
Journal:  PLoS One       Date:  2015-09-03       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.